MATCHPOINT THERAPEUTICS
Live / Applied — Fifth extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 11 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97212521
- Mark type
- Stylized text
- Filed
- 11 Jan 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease
Owner
- MATCHPOINT THERAPEUTICS INC., WATERTOWN, MA, US
- EoCys Inc., Cambridge, MA, US
- EoCys Inc., Cambridge, MA, US
Prosecution history
- 26 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 5 GRANTED
- 12 Feb 2026 — SOU EXTENSION 5 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 4 GRANTED
- 09 Jul 2025 — SOU EXTENSION 4 FILED
- 10 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2025 — SOU EXTENSION 3 GRANTED
- 27 Feb 2025 — SOU EXTENSION 3 FILED
- 27 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 2 GRANTED
- 04 Sept 2024 — SOU EXTENSION 2 FILED